Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01279083 · ClinicalTrials.gov registry record · Phase 1
Safety and Efficacy Trial to Treat Open-Angle Glaucoma or Ocular Hypertension
A Phase 1 study, sponsored by Santen.
- Completed
- Registry status
- Phase 1
- Development phase
- 147
- Enrollment target
NCT01279083 is a Phase 1 study that has completed, run by Santen. The registered enrollment target is 147 participants.
The verdict
NCT01279083, a Phase 1 study, has completed, sponsored by Santen.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 147 participants
- Enrollment target
Study Summary
To investigate the safety and efficacy of DE-112 in lowering intraocular pressure in subjects with primary open-angle glaucoma or ocular hypertension.
Interventions
- DRUG DE-112
- DRUG DE-112 Vehicle Solution
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 147 participants |
| Start Date | 2011-01 |
| Est. Completion | 2012-02 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01279083
The ClinicalTrials.gov registry entry for NCT01279083 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 147 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Santen, which has 32 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which DE-112 is the first listed.
NCT01279083 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01279083 about?
NCT01279083 is a clinical study titled "Safety and Efficacy Trial to Treat Open-Angle Glaucoma or Ocular Hypertension". To investigate the safety and efficacy of DE-112 in lowering intraocular pressure in subjects with primary open-angle glaucoma or ocular hypertension.
What is the current status of trial NCT01279083?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 147 participants. The study started on 2011-01. Estimated completion is 2012-02.
What interventions are being tested in trial NCT01279083?
The interventions under investigation include: DE-112 (DRUG), DE-112 Vehicle Solution (DRUG).
Who is sponsoring clinical trial NCT01279083?
This trial is sponsored by Santen, which has 32 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.